ELMO1 Polyclonal Antibody, APC-Cy7 Conjugated
Product Specifications
Background
ELMO1 is involved in cytoskeletal rearrangements required for phagocytosis of apoptotic cells and cell motility. ELMO1 acts in association with DOCK1 and CRK and was initially proposed to be required in complex with DOCK1 to activate Rac Rho small GTPases. It is belived to enhance the guanine nucleotide exchange factor (GEF) activity of DOCK1.
Synonyms
CED 12; Ced 12 homolog 1; Ced 12 homolog; CED12; Ced12 homolog 1; Ced12 homolog; ELMO 1; Engulfment and cell motility 1; Engulfment and cell motility protein 1; KIAA0281; ELMO1_HUMAN.
Gene ID
9844
Cellular Locus
Cytoplasm, Cell membrane
Host
Rabbit
Immunogen
581-680/727
Target
ELMO1
Clonality
Polyclonal
Isotype
IgG
Conjugation
APC-Cy7
Source
KLH conjugated synthetic peptide derived from human ELMO.
Applications
WB, IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
650nm/780nm
Concentration
1µg/µl
Dilution
WB (1:300-5000), IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
9844
Predicted Cross Reactivity
Human, Mouse, Rat, Dog, Cow, Chicken, Rabbit
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6199525-01 0.1 mL
ANAPC2 (Anaphase-promoting Complex Subunit 2, Cyclosome Subunit 2, APC2, KIAA1406, RP11-350O14.5) (MaxLight 490)
Ask
View Details 
MBS6199525-02 5x 0.1 mL
ANAPC2 (Anaphase-promoting Complex Subunit 2, Cyclosome Subunit 2, APC2, KIAA1406, RP11-350O14.5) (MaxLight 490)
Ask
View Details 